Herbert Boyer

Herbert Boyer, alongside Stanley Cohen, pioneered the technique of recombinant DNA in 1973. This groundbreaking process allowed scientists to cut and paste DNA from different organisms, forming the absolute foundation of modern genetic engineering.

Boyer co-founded Genentech in 1976 with venture capitalist Robert Swanson. Genentech became one of the first and most successful biotechnology companies in the world, ultimately paving the way for the modern biotech industry.

Boyer's recombinant DNA technology was famously utilized to produce human insulin, which was marketed as Humulin by Eli Lilly. This was the first commercially successful product of genetic engineering, replacing older animal-derived insulins for diabetes treatment.

Herbert Boyer conducted his critical scientific research at the University of California, San Francisco (UCSF). It was in his UCSF lab in the early 1970s that he and Stanley Cohen successfully cloned the first recombinant DNA molecules.